Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
A Phase 1, First-in-human Study of VX-668 (NCT05727800)Vertex Pharmaceuticals Incorporated2023-02-08
Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach (NCT05420727)John O. Prior2023-02-08
A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants (NCT05712460)Pfizer2023-02-08
A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine (NCT05685953)Matti Sällberg2023-02-08
[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine (NCT05522673)National Institute of Mental Health (NIMH)2023-02-08
Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM (NCT05739188)920th Hospital of Joint Logistics Support Force of People's Liberation Army of China2023-02-07
A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity (NCT05696847)Eli Lilly and Company2023-02-07
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems (NCT05661344)Boehringer Ingelheim2023-02-07
Investigating the Safety of LEO 158968 in Healthy Volunteers (NCT05682352)LEO Pharma2023-02-07
A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours (NCT05605522)3B Pharmaceuticals GmbH2023-02-07
A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric) (NCT05667506)Juventas Cell Therapy Ltd.2023-02-07
A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer (NCT05628870)Shandong Suncadia Medicine Co., Ltd.2023-02-07
Study of ST-1898 in Advanced Renal Cell Carcinoma (NCT06127238)Beijing Scitech-Mq Pharmaceuticals Limited2023-02-07
A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab (NCT05259709)Regeneron Pharmaceuticals2023-02-07
Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy (NCT05178992)Vanderbilt University2023-02-07
Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer (NCT05426005)Sun Yat-sen University2023-02-07
Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies (NCT05705570)Nelson Hamerschlak2023-02-07
Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients (NCT05293197)Assistance Publique - Hôpitaux de Paris2023-02-06
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (NCT05722418)Caribou Biosciences, Inc.2023-02-06
A Study of MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma (NCT05720052)MingSight Pharmaceuticals, Inc2023-02-06
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants (NCT05726851)Eisai Inc.2023-02-06
A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults (NCT06268301)Takeda2023-02-06
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects (NCT07169240)ScinnoHub Pharmaceutical Co., Ltd.2023-02-06
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung (NCT05611034)University Health Network, Toronto2023-02-06
Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases (NCT04812470)Vastra Gotaland Region2023-02-06
Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies (NCT05391490)University College, London2023-02-06
A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions (NCT05729386)GC Biopharma Corp2023-02-06
Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) (NCT05672121)Chengdu Origen Biotechnology Co., Ltd.2023-02-06
A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions (NCT05653869)Applied Pharmaceutical Science, Inc.2023-02-06
A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM (NCT05370508)SonALAsense, Inc.2023-02-06
CAR T Cells in Mesothelin-Expressing Breast Cancer (NCT05623488)University of Pennsylvania2023-02-06
Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA) (NCT05687279)Sanofi Pasteur, a Sanofi Company2023-02-06
Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor (NCT05745337)University of Vermont2023-02-06
Safety, Tolerability, and Pharmacokinetics of SPL84 in Healthy Volunteers (NCT06217952)SpliSense Ltd.2023-02-05
Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery (NCT06614010)Qianfoshan Hospital2023-02-05
Evaluation of Efficacy of Neem (Azadirachta Indica) Versus Triamcinolone Acetonide in the Treatment of Oral Lichen Planus. (NCT07141446)Goa Dental College2023-02-05
Safety and Tolerability of PRO-185 (NCT05470868)Laboratorios Sophia S.A de C.V.2023-02-04
A Research Study Looking Into Blood Levels of Three Different Formulations of the Study Medicine Ziltivekimab (NCT05721989)Novo Nordisk A/S2023-02-03
Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution (NCT05780086)Instituto Mexicano del Seguro Social2023-02-03
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease (NCT05647213)HeartWorks, Inc.2023-02-03
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT (NCT05739643)Forge Biologics, Inc2023-02-03
Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors (NCT05840835)Immix Biopharma, Inc.2023-02-03
Mirdametinib + BGB-3245 in Advanced Solid Tumors (NCT05580770)SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany2023-02-03
HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer (NCT05728619)Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.2023-02-03
Tau And Connectomics In TES Study (NCT05490576)Macquarie University, Australia2023-02-03
Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL) (NCT05747261)Biocad2023-02-02
A Study to Evaluate the PK, Safety and Tolerability of HCP1803. (NCT05723549)Hanmi Pharmaceutical Company Limited2023-02-02
Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer (NCT05880485)Peking Union Medical College Hospital2023-02-02
Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects (NCT05638126)Shandong Suncadia Medicine Co., Ltd.2023-02-02
A Randomized Controlled Trial of a Digital, Self-testing Strategy for COVID-19 Infection in South Africa. (NCT05436795)McGill University Health Centre/Research Institute of the McGill University Health Centre2023-02-02
BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT05703542)Eric Stephen Winer, MD2023-02-02
[18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy Subjects (NCT05564429)National Institute of Mental Health (NIMH)2023-02-02
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus (NCT06040177)First Affiliated Hospital of Guangxi Medical University2023-02-02
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer (NCT05492682)Valo Therapeutics Oy2023-02-02
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers (NCT05395624)Ashvattha Therapeutics, Inc.2023-02-02
Clinical Study on the Efficacy and Safety of Qingre Heji in the Treatment of Acute Upper Respiratory Tract Infection (NCT06520618)Shengjing Hospital2023-02-01
BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer (NCT05715398)Shanghai Gopherwood Biotech Co., Ltd.2023-02-01
Study of HS-10517 in Chinese Adult Participants (NCT05779579)Jiangsu Hansoh Pharmaceutical Co., Ltd.2023-02-01
Biological and Behavioral Outcomes of Community Nature Walks (NCT06056375)Charlotte Tate2023-02-01
Study to Assess Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma (NCT05308225)Sorrento Therapeutics, Inc.2023-02-01
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD (NCT05897606)Sulaimani Polytechnic University2023-02-01
Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer (NCT05684731)Tongji Hospital2023-02-01
Concentrated Platelet Rich Fibrin (C-PRF) as Adjunct to Non-surgical Periodontal Therapy (NCT05958147)Krishnadevaraya College of Dental Sciences & Hospital2023-02-01
Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer (NCT05693090)Kura Oncology, Inc.2023-02-01
Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer (NCT05544227)Williams Cancer Foundation2023-02-01
Comparison Between Oral Melatonin and Hydroxyzine in Pediatric Patients Undergoing Adenotonsillectomy (NCT05680584)Minia University2023-02-01
Effects of Lemborexant as a Treatment for Moderate-to-severe OSA Patients With Low Arousal Threshold (NCT05763329)Chulalongkorn University2023-02-01
The Anticariogenic Effect of Silver Diamine Fluoride and Sodium Fluoride Varnish (NCT06316323)Universiti Teknologi Mara2023-02-01
Effect of Basis™ and High Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance (NCT04050358)Elysium Health2023-02-01
R21 Roche: 3-Way Tau Tracers in AD (NCT05464368)Washington University School of Medicine2023-02-01
Phase Ib Clinical Study on the Safety, the Tolerability, the Pharmacokinetics and the Efficacy of ScTIL Injection (Gene Modified Tumor Infiltrating Lymphocytes) Alone and in Combination With B Lymphocyte Adjuvant in the Treatment of Digestive System Malignant Solid Tumors (NCT05730361)Peking University2023-02-01
To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100 (NCT05684718)BioVersys AG2023-02-01
Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss (NCT05986266)Egymedicalpedia2023-02-01
Study of CMAB807X Pre- and Post-change in Manufacturing Site and Xgeva® in Healthy Volunteers (NCT05808673)Taizhou Mabtech Pharmaceutical Co.,Ltd2023-02-01
Safety Profile Comparison of Undiluted Intracameral Moxifloxacin vs. Levofloxacin in Cataract Surgery (NCT05741632)Indonesia University2023-02-01
Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease (NCT05691114)Shanghai East Hospital2023-02-01
WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Multiple Sclerosis (NCT05755061)Kessler Foundation2023-02-01
Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD (NCT05686174)National Taiwan University Hospital2023-02-01
Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors (NCT05544240)Williams Cancer Foundation2023-02-01
CISH Inactivated TILs in the Treatment of NSCLC (NCT05566223)Intima Bioscience, Inc.2023-02-01
A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT05703204)Qilu Pharmaceutical Co., Ltd.2023-02-01
Mepolizumab for Eosinophilic Fasciitis (NCT04305678)Mayo Clinic2023-02-01
A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems (NCT05718843)Boehringer Ingelheim2023-02-01
Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition (NCT05673369)Chong Kun Dang Pharmaceutical2023-02-01
Efficacy of Adding Low Dose Ketamine or Fentanyl to Propofol-dexmedetomidine as Total Intravenous Anesthesia (NCT06031883)Minia University2023-02-01
Assessment of Photodynamic Therapy With Annatto and Led for the Treatment of Halitosis in Mouth-Breathing Children (NCT05590897)University of Nove de Julho2023-02-01
Immunotherapy With CD19 CAR T-cells for B-Cell Leukemia (NCT04100187)Kecellitics Biotech Company Ltd2023-02-01
"The Effect Of Subcutaneous Epinephrine Dosage On Blood Loss In Surgical Incision" (NCT05670808)Dow University of Health Sciences2023-02-01
Efficacy Assessment of Chinese Herbal Medicine Tangweian Recipe Treating Participants With Diabetic Gastroenteropathy (NCT05720442)Guang'anmen Hospital of China Academy of Chinese Medical Sciences2023-02-01
Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution (NCT05481489)Laboratorios Sophia S.A de C.V.2023-02-01
Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants (NCT05599802)AIM Vaccine Co., Ltd.2023-02-01
Potential Drug Interaction Between ALXN2040 and Rosuvastatin (NCT05708573)Alexion Pharmaceuticals, Inc.2023-02-01
Cell Therapy for IBM by Muscle Injection of ADSVF (NCT05032131)Assistance Publique - Hôpitaux de Paris2023-02-01
Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities (NCT05301361)University of California, Davis2023-02-01
Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours (NCT05478486)Godavari Biorefineries Limited2023-02-01
Augmenting Ankle Plantarflexor Function in Cerebral Palsy (NCT05154253)Northern Arizona University2023-02-01
Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer (NCT05775900)Sun Yat-sen University2023-02-01
To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS (NCT05740917)Xuanzhu Biopharmaceutical Co., Ltd.2023-02-01
Enhancing Processing Speed and Executive Functioning in Depressed Older Adults With Computerized Cognitive Training (NCT04836533)Queens College, The City University of New York2023-01-31
Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients (NCT05664906)Chinese University of Hong Kong2023-01-31
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.